Analysts Forecast 10% Growth for VIOV in the Near Future
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 24 2025
0mins
Should l Buy HSTM?
Source: NASDAQ.COM
ETF Analysis: The Vanguard S&P Small-Cap 600 Value ETF (VIOV) has an implied analyst target price of $105.34, indicating a potential upside of 10.04% from its current trading price of $95.73.
Notable Holdings: Key underlying holdings with significant upside potential include Pacira BioSciences (PCRX), Healthstream (HSTM), and Apple Hospitality REIT (APLE), each showing expected price increases of around 10% based on analyst targets.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy HSTM?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on HSTM
Wall Street analysts forecast HSTM stock price to rise
4 Analyst Rating
2 Buy
2 Hold
0 Sell
Moderate Buy
Current: 20.970
Low
25.00
Averages
25.00
High
25.00
Current: 20.970
Low
25.00
Averages
25.00
High
25.00
About HSTM
HealthStream, Inc. provides platform-delivered workforce solutions. Its solutions include Software-as-a-Service (SaaS), subscription-based applications used by healthcare organizations to meet a range of their workforce development needs around learning, clinical development, credentialing, and scheduling. Its content libraries allow customers to subscribe to an array of courseware, which includes content from healthcare and nursing associations, medical and healthcare publishers, and other content providers. Its scheduling solutions provide customers with real-time visibility into clinical staff scheduling. Its credentialing, privileging, and enrollment solution, CredentialStream, provides customers a user experience with a continual stream of enhancements, evidence-based content, and curated data, which provides healthcare organizations with tools to support the provider lifecycle management from recruiting, application submission, verification of licensure, and other credentials.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
HealthStream Approves New Share Repurchase Program
- Repurchase Program Scale: HealthStream's Board of Directors has approved a new share repurchase program allowing the company to buy back up to $10 million of common stock, aimed at enhancing shareholder value and reflecting confidence in its stock.
- Flexible Repurchase Methods: The repurchases may be conducted through open market transactions, privately negotiated deals, or other means, demonstrating the company's adaptability to market conditions and liquidity considerations.
- Defined Repurchase Timeline: The repurchase program will terminate on September 12, 2026, or when the maximum dollar amount is reached, ensuring financial flexibility while not mandating the acquisition of any specific number of shares.
- Market Risk Advisory: The company cautions investors that the repurchase program is subject to various factors including market conditions, liquidity, and cash flow, emphasizing the uncertainties surrounding future outcomes and advising investors to exercise caution regarding forward-looking statements.
See More
HealthStream Approves $10 Million Share Repurchase Program
- Repurchase Program Approval: HealthStream announced the approval of a new share repurchase program allowing the company to buy back up to $10 million of its outstanding common stock, aimed at enhancing shareholder value and boosting market confidence.
- Market Execution Method: Under this program, share repurchases will be made occasionally in the open market, indicating the company's confidence in its stock while potentially providing short-term support for the share price.
- Financial Performance Beats Expectations: HealthStream reported a non-GAAP EPS of $0.18, beating expectations by $0.01, and revenue of $79.7 million, exceeding forecasts by $3.49 million, demonstrating strong performance in revenue growth and profitability.
- Future Outlook: The company has set a revenue target of $323 million to $330 million for 2026, reflecting its strategic commitment to advancing its AI-enabled platform and ecosystem, which is expected to further drive business growth.
See More
HEALTHSTREAM INTRODUCES SHARE BUYBACK INITIATIVE
Program Announcement: HealthStream has announced a new Share Repurchase Program aimed at enhancing shareholder value.
Repurchase Details: The program allows for the repurchase of up to $50 million of the company's common stock over a specified period.
Strategic Intent: This initiative reflects HealthStream's commitment to returning capital to shareholders and optimizing its capital structure.
Market Impact: The announcement is expected to positively influence investor confidence and potentially boost the company's stock price.
See More
HealthStream Reports Q4 2025 Earnings with Strong Growth and Strategic Acquisitions
- Significant Revenue Growth: HealthStream reported Q4 2025 revenues of $79.7 million, reflecting a 7.4% year-over-year increase, with subscription product revenues rising by $5.8 million, indicating strong market performance and heightened customer demand.
- Adjusted EBITDA Improvement: The adjusted EBITDA reached $18.8 million, up 16.4% year-over-year, despite operating income declining by 48.8% to $2.4 million, showcasing the company's solid profitability and effective cost management.
- Acquisitions and Share Buyback: The company completed two acquisitions in 2025, namely Virsys12 and MissionCare Collective, and initiated a $10 million share repurchase program in November, reflecting confidence in future growth and flexibility in capital allocation.
- Optimistic 2026 Outlook: Management projects 2026 revenues between $323 million and $330 million, with net income expected between $20.4 million and $22.8 million, indicating a positive outlook on market demand and a strategic plan for sustained growth.
See More
HealthStream Declares 12.9% Increase in Quarterly Dividend
- Dividend Increase: HealthStream declares a quarterly dividend of $0.035 per share, representing a 12.9% increase from the previous $0.031, indicating the company's commitment to stable cash flow and shareholder returns.
- Yield Metrics: The forward yield of 0.66% reflects the company's attractiveness to investors in the current market environment, aiming to bolster shareholder confidence and attract further investment.
- Earnings Beat: HealthStream reports a non-GAAP EPS of $0.18, beating expectations by $0.01, with revenue of $79.7 million exceeding forecasts by $3.49 million, showcasing the company's competitive edge and sustained profitability.
- Acquisition Strategy: HealthStream's acquisition of MissionCare Collective for up to $40 million aims to drive future growth by expanding service offerings and enhancing market share, further solidifying its position in the healthcare sector.
See More
HealthStream Q4 Earnings Beat Expectations with Strategic Acquisitions
- Strong Earnings Report: HealthStream reported a Q4 non-GAAP EPS of $0.18, beating expectations by $0.01, with revenue of $79.7 million reflecting a 7.4% year-over-year increase, surpassing estimates by $3.49 million, indicating robust market performance.
- Strategic Acquisitions: The company completed acquisitions of Virsys12 and MissionCare Collective for up to $40 million, aimed at enhancing service capabilities and competitive positioning through resource integration.
- Share Repurchase Program: HealthStream authorized a share repurchase program to buy back up to $10 million of common stock by November 11, 2025, having already repurchased $5 million in Q4, with another $5 million planned for January 2026, aimed at enhancing shareholder value.
- Full-Year Performance Overview: Total revenues for 2025 reached $304.1 million, up 4.3%, although operating income fell 4.9% to $20.2 million, primarily impacted by the CEO stock gift; excluding this, non-GAAP operating income was $24 million, reflecting a 12.8% increase, indicating improved profitability on an adjusted basis.
See More
HealthStream Approves New Share Repurchase Program
- Repurchase Program Scale: HealthStream's Board of Directors has approved a new share repurchase program allowing the company to buy back up to $10 million of common stock, aimed at enhancing shareholder value and reflecting confidence in its stock.
- Flexible Repurchase Methods: The repurchases may be conducted through open market transactions, privately negotiated deals, or other means, demonstrating the company's adaptability to market conditions and liquidity considerations.
- Defined Repurchase Timeline: The repurchase program will terminate on September 12, 2026, or when the maximum dollar amount is reached, ensuring financial flexibility while not mandating the acquisition of any specific number of shares.
- Market Risk Advisory: The company cautions investors that the repurchase program is subject to various factors including market conditions, liquidity, and cash flow, emphasizing the uncertainties surrounding future outcomes and advising investors to exercise caution regarding forward-looking statements.
See More
HealthStream Approves $10 Million Share Repurchase Program
- Repurchase Program Approval: HealthStream announced the approval of a new share repurchase program allowing the company to buy back up to $10 million of its outstanding common stock, aimed at enhancing shareholder value and boosting market confidence.
- Market Execution Method: Under this program, share repurchases will be made occasionally in the open market, indicating the company's confidence in its stock while potentially providing short-term support for the share price.
- Financial Performance Beats Expectations: HealthStream reported a non-GAAP EPS of $0.18, beating expectations by $0.01, and revenue of $79.7 million, exceeding forecasts by $3.49 million, demonstrating strong performance in revenue growth and profitability.
- Future Outlook: The company has set a revenue target of $323 million to $330 million for 2026, reflecting its strategic commitment to advancing its AI-enabled platform and ecosystem, which is expected to further drive business growth.
See More
HEALTHSTREAM INTRODUCES SHARE BUYBACK INITIATIVE
Program Announcement: HealthStream has announced a new Share Repurchase Program aimed at enhancing shareholder value.
Repurchase Details: The program allows for the repurchase of up to $50 million of the company's common stock over a specified period.
Strategic Intent: This initiative reflects HealthStream's commitment to returning capital to shareholders and optimizing its capital structure.
Market Impact: The announcement is expected to positively influence investor confidence and potentially boost the company's stock price.
See More
HealthStream Reports Q4 2025 Earnings with Strong Growth and Strategic Acquisitions
- Significant Revenue Growth: HealthStream reported Q4 2025 revenues of $79.7 million, reflecting a 7.4% year-over-year increase, with subscription product revenues rising by $5.8 million, indicating strong market performance and heightened customer demand.
- Adjusted EBITDA Improvement: The adjusted EBITDA reached $18.8 million, up 16.4% year-over-year, despite operating income declining by 48.8% to $2.4 million, showcasing the company's solid profitability and effective cost management.
- Acquisitions and Share Buyback: The company completed two acquisitions in 2025, namely Virsys12 and MissionCare Collective, and initiated a $10 million share repurchase program in November, reflecting confidence in future growth and flexibility in capital allocation.
- Optimistic 2026 Outlook: Management projects 2026 revenues between $323 million and $330 million, with net income expected between $20.4 million and $22.8 million, indicating a positive outlook on market demand and a strategic plan for sustained growth.
See More
HealthStream Declares 12.9% Increase in Quarterly Dividend
- Dividend Increase: HealthStream declares a quarterly dividend of $0.035 per share, representing a 12.9% increase from the previous $0.031, indicating the company's commitment to stable cash flow and shareholder returns.
- Yield Metrics: The forward yield of 0.66% reflects the company's attractiveness to investors in the current market environment, aiming to bolster shareholder confidence and attract further investment.
- Earnings Beat: HealthStream reports a non-GAAP EPS of $0.18, beating expectations by $0.01, with revenue of $79.7 million exceeding forecasts by $3.49 million, showcasing the company's competitive edge and sustained profitability.
- Acquisition Strategy: HealthStream's acquisition of MissionCare Collective for up to $40 million aims to drive future growth by expanding service offerings and enhancing market share, further solidifying its position in the healthcare sector.
See More
HealthStream Q4 Earnings Beat Expectations with Strategic Acquisitions
- Strong Earnings Report: HealthStream reported a Q4 non-GAAP EPS of $0.18, beating expectations by $0.01, with revenue of $79.7 million reflecting a 7.4% year-over-year increase, surpassing estimates by $3.49 million, indicating robust market performance.
- Strategic Acquisitions: The company completed acquisitions of Virsys12 and MissionCare Collective for up to $40 million, aimed at enhancing service capabilities and competitive positioning through resource integration.
- Share Repurchase Program: HealthStream authorized a share repurchase program to buy back up to $10 million of common stock by November 11, 2025, having already repurchased $5 million in Q4, with another $5 million planned for January 2026, aimed at enhancing shareholder value.
- Full-Year Performance Overview: Total revenues for 2025 reached $304.1 million, up 4.3%, although operating income fell 4.9% to $20.2 million, primarily impacted by the CEO stock gift; excluding this, non-GAAP operating income was $24 million, reflecting a 12.8% increase, indicating improved profitability on an adjusted basis.
See More
